CryoCor’s Cryoablation System For Atrial Flutter Is Non-Approvable, FDA Says
This article was originally published in The Gray Sheet
Executive Summary
CryoCor is planning to amend its PMA after receiving a non-approvable letter from FDA for its CryoCor cardiac cryoablation system for the treatment of atrial flutter, according to CEO Greg Ayers, MD